Literature DB >> 30358115

Overproduction of Tenascin-C Driven by Lipid Accumulation in the Liver Aggravates Hepatic Ischemia/Reperfusion Injury in Steatotic Mice.

Hiroyuki Kato1, Sergio Duarte1, Mary G Miller1, Ronald W Busuttil1, Ana J Coito1.   

Abstract

The purpose of this study was to assess the significance of tenascin-C (Tnc) expression in steatotic liver ischemia/reperfusion injury (IRI). The critical shortage in donor organs has led to the use of steatotic livers in transplantation regardless of their elevated susceptibility to hepatic IRI. Tnc is an endogenous danger signal extracellular matrix molecule involved in various aspects of immunity and tissue injury. In the current study, mice were fed with a steatosis-inducing diet and developed approximately 50% hepatic steatosis, predominantly macrovesicular, before being subjected to hepatic IRI. We report here that lipid accumulation in hepatocytes inflated the production of Tnc in steatotic livers and in isolated hepatic stellate cells. Moreover, we show that the inability of Tnc-/- deficient steatotic mice to express Tnc significantly protected these mice from liver IRI. Compared with fatty controls, Tnc-/- steatotic mice showed significantly reduced serum transaminase levels and enhanced liver histological preservation at both 6 and 24 hours after hepatic IRI. The lack of Tnc expression resulted in impaired lymphocyte antigen 6 complex, locus (Ly6G) neutrophil and macrophage antigen-1 (Mac-1) leukocyte recruitment as well as in decreased expression of proinflammatory mediators (interleukin 1β, tumor necrosis factor α, and chemokine [C-X-C motif] ligand 2) after liver reperfusion. Myeloperoxidase (MPO) is the most abundant cytotoxic enzyme secreted by neutrophils and a key mediator of neutrophil-induced oxidative tissue injuries. Using an in vitro model of steatosis, we also show that Tnc markedly potentiated the effect of steatotic hepatocytes on neutrophil-derived MPO activity. In conclusion, our data support the view that inhibition of Tnc is a promising therapeutic approach to lessen inflammation in steatotic livers and to maximize their successful use in organ transplantation.
Copyright © 2018 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30358115      PMCID: PMC6355355          DOI: 10.1002/lt.25365

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  50 in total

Review 1.  Adipose tissue remodeling in pathophysiology of obesity.

Authors:  Mi-Jeong Lee; Yuanyuan Wu; Susan K Fried
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2010-07       Impact factor: 4.294

2.  Local production of tenascin-C acts as a trigger for monocyte/macrophage recruitment that provokes cardiac dysfunction.

Authors:  Dounia Abbadi; Fanny Laroumanie; Mathilde Bizou; Joffrey Pozzo; Danièle Daviaud; Christine Delage; Denis Calise; Fréderique Gaits-Iacovoni; Marianne Dutaur; Florence Tortosa; Edith Renaud-Gabardos; Victorine Douin-Echinard; Anne-Catherine Prats; Jerome Roncalli; Angelo Parini; Nathalie Pizzinat
Journal:  Cardiovasc Res       Date:  2018-01-01       Impact factor: 10.787

3.  Seven steps to stellate cells.

Authors:  Patrick Maschmeyer; Melanie Flach; Florian Winau
Journal:  J Vis Exp       Date:  2011-05-10       Impact factor: 1.355

Review 4.  Tissue injury in neutrophilic inflammation.

Authors:  F Dallegri; L Ottonello
Journal:  Inflamm Res       Date:  1997-10       Impact factor: 4.575

Review 5.  Innate immune responses to trauma.

Authors:  Markus Huber-Lang; John D Lambris; Peter A Ward
Journal:  Nat Immunol       Date:  2018-03-05       Impact factor: 25.606

Review 6.  Leukocyte transmigration across endothelial and extracellular matrix protein barriers in liver ischemia/reperfusion injury.

Authors:  Ana J Coito
Journal:  Curr Opin Organ Transplant       Date:  2011-02       Impact factor: 2.640

Review 7.  Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver.

Authors:  Scott L Friedman
Journal:  Physiol Rev       Date:  2008-01       Impact factor: 37.312

Review 8.  Neutrophil proteolytic activation cascades: a possible mechanistic link between chronic periodontitis and coronary heart disease.

Authors:  Hatem Alfakry; Ernst Malle; Chintan N Koyani; Pirkko J Pussinen; Timo Sorsa
Journal:  Innate Immun       Date:  2015-11-24       Impact factor: 2.680

9.  The role of tenascin-C in tissue injury and tumorigenesis.

Authors:  Kim S Midwood; Gertraud Orend
Journal:  J Cell Commun Signal       Date:  2009-10-17       Impact factor: 5.782

10.  Hepatic ischemia and reperfusion injury in the absence of myeloid cell-derived COX-2 in mice.

Authors:  Sergio Duarte; Hiroyuki Kato; Naohisa Kuriyama; Kathryn Suko; Tomo-O Ishikawa; Ronald W Busuttil; Harvey R Herschman; Ana J Coito
Journal:  PLoS One       Date:  2014-05-12       Impact factor: 3.240

View more
  3 in total

1.  Tenascin-C induction exacerbates post-stroke brain damage.

Authors:  Bharath Chelluboina; Anil K Chokkalla; Suresh L Mehta; Kahlilia C Morris-Blanco; Saivenkateshkomal Bathula; Sneha Sankar; Jin Soo Park; Raghu Vemuganti
Journal:  J Cereb Blood Flow Metab       Date:  2021-10-25       Impact factor: 6.960

2.  Enhanced migration and adhesion of peripheral blood neutrophils from SAPHO patients revealed by RNA-Seq.

Authors:  Yuxiu Sun; Chen Li; Mengmeng Zhu; Shen Zhang; Yihan Cao; Qiao Yang; Pengfei Zhao; Guangrui Huang; Anlong Xu
Journal:  Orphanet J Rare Dis       Date:  2019-08-08       Impact factor: 4.123

3.  Luteolin Pretreatment Attenuates Hepatic Ischemia-Reperfusion Injury in Mice by Inhibiting Inflammation, Autophagy, and Apoptosis via the ERK/PPARα Pathway.

Authors:  Yuhui Jiang; Wenjuan Yang; Jiameng Ding; Jie Ji; Liwei Wu; Yuanyuan Zheng; Yan Li; Ziqi Cheng; Jie Zhang; Qiang Yu; Jiao Feng; Jingjing Li; Jianye Wu; Yingqun Zhou; Chuanyong Guo
Journal:  PPAR Res       Date:  2022-08-03       Impact factor: 4.385

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.